Daily brief
Gilead Sciences has agreed to acquire German biotech firm Tubulis for up to $5 billion, aiming to strengthen its pipeline of cancer therapies. The deal underscores ongoing consolidation in the pharmaceutical sector as companies seek innovative oncology treatments.
Rimac Technology, based in Zagreb, will produce the battery system for the new BMW i7 electric sedan, highlighting the Croatian firm's growing role in the global automotive supply chain.
North Sea gas production saves Britain billions of pounds annually, according to a new analysis.
German power prices turned deeply negative on Monday due to a surge in renewable energy generation, reflecting grid oversupply.
An economist warned that an escalation of the Iran conflict could lead to major price increases globally.